Literature DB >> 18724069

Macrophage phenotype and renal fibrosis in obstructive nephropathy.

Masashi Nishida1, Kenji Hamaoka.   

Abstract

Macrophages have classically been recognized as key players that may promote renal fibrosis. However, several recent studies have suggested a beneficial anti-fibrotic role of infiltrating macrophages that acts to preserve renal architecture in the progressive renal scarring associated with obstructive nephropathy. Furthermore, recent investigations indicate a role for macrophages in both inflammation and repair during disease processes and this has superseded the classical injurious view of macrophages. As a result, the exact role of interstitial macrophages upon various facets of renal fibrosis is an important challenge that needs to be addressed. In this article, we discuss the possible beneficial anti-fibrotic role of infiltrating macrophages in obstructive nephropathy and discuss the potential mechanisms that may regulate the effect of macrophages upon renal interstitial fibrosis. Copyright (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 18724069     DOI: 10.1159/000151561

Source DB:  PubMed          Journal:  Nephron Exp Nephrol        ISSN: 1660-2129


  16 in total

1.  Identification and regulation of reticulon 4B (Nogo-B) in renal tubular epithelial cells.

Authors:  Ethan P Marin; Gilbert Moeckel; Rafia Al-Lamki; John Bradley; Qingshang Yan; Tong Wang; Paulette L Wright; Jun Yu; William C Sessa
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

2.  Losartan accelerates the repair process of renal fibrosis in UUO mouse after the surgical recanalization by upregulating the expression of Tregs.

Authors:  Jie Song; Yangyang Xia; Xiang Yan; Jia Luo; Chunming Jiang; Miao Zhang; Guo-Ping Shi; Wei Zhu
Journal:  Int Urol Nephrol       Date:  2019-08-10       Impact factor: 2.370

Review 3.  Renal fibrosis: novel insights into mechanisms and therapeutic targets.

Authors:  Peter Boor; Tammo Ostendorf; Jürgen Floege
Journal:  Nat Rev Nephrol       Date:  2010-09-14       Impact factor: 28.314

4.  HMGB1 exacerbates renal tubulointerstitial fibrosis through facilitating M1 macrophage phenotype at the early stage of obstructive injury.

Authors:  Shaojiang Tian; Lansing Zhang; Junming Tang; Xia Guo; Kun Dong; Shi-You Chen
Journal:  Am J Physiol Renal Physiol       Date:  2014-11-05

5.  Identification of a microRNA signature in renal fibrosis: role of miR-21.

Authors:  Abolfazl Zarjou; Shanzhong Yang; Edward Abraham; Anupam Agarwal; Gang Liu
Journal:  Am J Physiol Renal Physiol       Date:  2011-07-20

Review 6.  The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis.

Authors:  Marcus R Clark; Kimberly Trotter; Anthony Chang
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

7.  Role of inflammation in túbulo-interstitial damage associated to obstructive nephropathy.

Authors:  María T Grande; Fernando Pérez-Barriocanal; José M López-Novoa
Journal:  J Inflamm (Lond)       Date:  2010-04-22       Impact factor: 4.981

8.  Dual effect of chemokine CCL7/MCP-3 in the development of renal tubulointerstitial fibrosis.

Authors:  Julien Gonzalez; Sofia Mouttalib; Christine Delage; Denis Calise; Jean-José Maoret; Jean-Philippe Pradère; Julie Klein; Bénédicte Buffin-Meyer; Betty Van der Veen; Israel F Charo; Peter Heeringa; Johan Duchene; Jean-Loup Bascands; Joost-Peter Schanstra
Journal:  Biochem Biophys Res Commun       Date:  2013-07-19       Impact factor: 3.575

9.  Renal macrophage infiltration is associated with a poor outcome in IgA nephropathy.

Authors:  Gyl Eanes Barros Silva; Roberto Silva Costa; Roberto Cuan Ravinal; Leandra Naira Zambelli Ramalho; Marlene Antonia dos Reis; Miguel Moyses-Neto; Elen Almeida Romao; Terezila Machado Coimbra; Márcio Dantas
Journal:  Clinics (Sao Paulo)       Date:  2012-07       Impact factor: 2.365

10.  Hypertensive nephropathy treatment by heart-protecting musk pill: a study of anti-inflammatory therapy for target organ damage of hypertension.

Authors:  Dengke Tian; Shuang Ling; Gangling Chen; Yajuan Li; Jun Liu; Murad Ferid; Ka Bian
Journal:  Int J Gen Med       Date:  2011-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.